Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Page 2

buy button

Energy Stocks Highlight Slow Earnings Season Insider Buying: Summit Midstream, Western Refining Logistics, Monsanto and More

Regular 24/7 Wall St. readers know that earnings season typically slows the rate of insider activity in a big way. Corporations go into what is called the silent period, before, ...
Read Full Story »
biotech word cloud

Top 6 Biopharma Movers of the Past Week

Over the past week, a few biotech companies made impressive runs. These moves were the result of clinical trial results, U.S. Food and Drug Administration (FDA) decisions and more. The ...
Read Full Story »
automatic inspection machine

Inovio Fails to Impress With HPV Business Update

Inovio Pharmaceuticals Inc. (NASDAQ: INO) made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment. The company announced a clinical strategy update to take its INO-3112 HPV ...
Read Full Story »
Ebola Virus

How the Inovio Secondary Crushed Its Shareholders

A lot of times when companies have secondary offerings, the price takes a slight dip to accommodate the dilution and price. However a landslide drop of almost 15% is not ...
Read Full Story »
payoff

Insider Buying This Week Dominated by Pharma and Yield Chasers

Investors love to see insiders at high corporate levels purchasing their own companies' stock. That is particularly true if the stock has performed well and has traded to higher levels. ...
Read Full Story »
research

Top Biotech Stocks Under $5 With Huge Potential Upside

With the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Lower, Mixed at Closing

August 5, 2013: U.S. equity markets opened lower this morning, lacking any major news of interest from around the globe. In Europe, eurozone non-manufacturing PMI rose slightly even though German ...
Read Full Story »

BioHealth Business Daily (ABIO, GENZ, SOMX, CRXX, VVUS, INO)

Today was a crazy day for the markets, and as you'd expect there were many movers in the drug and biotech sectors.  Today's edition of the BioHealth Business Daily covers ...
Read Full Story »
biotech

Swine Flu Research Causes 165% Surge In Inovio (INO)

As first reported at our affiliate site BioHealth Investor: Inovio Biomedical Corporation (NYSE Amex: INO) has been higher by over 160% for most of the morning.  Investors are following the news ...
Read Full Story »

Pre-Market Stock News (June 19, 2007)

(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: ...
Read Full Story »